On September 8, UiPath fell 5.66% in regular trading, trading at $13.975/share, with turnover of $112 million. The stock continued to slide as the market digested the company's fiscal Q2 results and a wave of cautious analyst commentary.

UiPath reported Q2 revenue of $410.3 million, beating the FactSet consensus estimate of $397.8 million, but adjusted EPS of $0.15 was flat year-over-year, signaling stalled profit growth. Although the company raised its full-year revenue guidance to $1.789–$1.794 billion, above the prior $1.776–$1.781 billion range, Oppenheimer noted limited evidence of sustained growth re-acceleration, with the revenue beat primarily driven by professional services and licenses rather than core subscription momentum. The company also announced a CFO transition, promoting Hitesh Ramani to replace Ashim Gupta, adding to market uncertainty.

While Citigroup initiated coverage with a Buy rating and a $23 price target, the broader analyst consensus remains at Hold with a mean target of $16.96. Truist and RBC both reiterated Hold-equivalent ratings, lifting targets modestly to $17. UBS maintained Neutral at $19. The stock has declined roughly 17% since earnings were released on September 3.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)